/
/
/

Syncom Formulations (India) Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
-21%30%5%
-49%56%55%
--36%37%
11%13%15%20%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
LAURUSLABS
CIPLA
DRREDDY
MANKIND
AUROPHARMA
LUPIN
SYNCOMF
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,764₹419620 Cr34.6912.0762.82₹11479 Cr
9,030₹239714 Cr81.9534.04128.41₹2568 Cr
4,584.1₹174741 Cr80.1216.7297.06₹2163 Cr
1,140.2₹112119 Cr24.849.4262.53₹5040 Cr
2,018.5₹110008 Cr100.616.829.25₹889 Cr
1,328₹106061 Cr31.479.7757.87₹3879 Cr
1,218.8₹101339 Cr31.455.3263.99₹4196 Cr
2,347.6₹96244 Cr47.1213.7571.08₹1913 Cr
1,677.9₹95590 Cr25.7517.9596.84₹3505 Cr
1,980.9₹89391 Cr16.1730.95154.35₹5333 Cr
21.56₹2112 Cr24.70.260.98₹76 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Dec 2013Mar 2013Dec 2012Mar 2012
₹126 Cr₹135 Cr₹115 Cr₹122 Cr₹117 Cr₹149 Cr₹128 Cr₹102 Cr₹87 Cr₹75 Cr₹65 Cr₹64 Cr₹60 Cr₹61 Cr₹57 Cr₹54 Cr₹51 Cr₹58 Cr₹57 Cr₹53 Cr₹41 Cr₹35 Cr₹34 Cr₹27 Cr
₹8 Cr₹15 Cr₹6 Cr₹5 Cr₹6 Cr₹7 Cr₹4 Cr₹4 Cr₹1 Cr₹3 Cr₹5 Cr₹4 Cr₹2 Cr₹7 Cr₹2 Cr₹3 Cr₹3 Cr₹6 Cr₹2 Cr₹3 Cr₹25 L₹49 L₹40 L₹53 L
₹133 Cr₹150 Cr₹121 Cr₹127 Cr₹123 Cr₹156 Cr₹132 Cr₹106 Cr₹89 Cr₹78 Cr₹70 Cr₹68 Cr₹62 Cr₹68 Cr₹59 Cr₹57 Cr₹54 Cr₹64 Cr₹59 Cr₹56 Cr₹41 Cr₹35 Cr₹35 Cr₹27 Cr
₹101 Cr₹116 Cr₹95 Cr₹105 Cr₹102 Cr₹132 Cr₹114 Cr₹91 Cr₹78 Cr₹66 Cr₹59 Cr₹58 Cr₹54 Cr₹56 Cr₹53 Cr₹51 Cr₹49 Cr₹57 Cr₹53 Cr₹48 Cr₹37 Cr₹33 Cr₹31 Cr₹27 Cr
₹34 Cr₹37 Cr₹27 Cr₹24 Cr₹22 Cr₹25 Cr₹19 Cr₹16 Cr₹12 Cr₹13 Cr₹12 Cr₹10 Cr₹8 Cr₹13 Cr₹8 Cr₹7 Cr₹6 Cr₹8 Cr₹7 Cr₹8 Cr₹5 Cr₹3 Cr₹4 Cr₹1 Cr
₹25 L₹38 L₹26 L₹27 L₹25 L₹12 L₹20 L₹16 L₹39 L₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹72 L₹62 L₹50 L₹1 Cr₹15 L₹12 L₹2 L₹9 L₹11 L₹15 L
₹32 Cr₹34 Cr₹25 Cr₹22 Cr₹20 Cr₹23 Cr₹17 Cr₹15 Cr₹10 Cr₹10 Cr₹9 Cr₹8 Cr₹6 Cr₹10 Cr₹6 Cr₹5 Cr₹5 Cr₹6 Cr₹6 Cr₹7 Cr₹4 Cr₹2 Cr₹3 Cr₹20 L
₹25 Cr₹25 Cr₹19 Cr₹17 Cr₹16 Cr₹18 Cr₹13 Cr₹11 Cr₹8 Cr₹7 Cr₹7 Cr₹7 Cr₹4 Cr₹8 Cr₹4 Cr₹4 Cr₹4 Cr₹5 Cr₹4 Cr₹6 Cr₹3 Cr₹1 Cr₹2 Cr-₹85 L

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013
——————————
₹94 Cr₹94 Cr₹94 Cr₹94 Cr₹86 Cr₹78 Cr₹78 Cr₹78 Cr₹78 Cr₹22 Cr
₹0₹0₹0₹0₹5 Cr₹0₹0₹0₹0₹0
₹321 Cr₹248 Cr₹194 Cr₹162 Cr₹131 Cr₹39 Cr₹31 Cr₹22 Cr₹17 Cr₹65 Cr
₹321 Cr₹248 Cr₹194 Cr₹162 Cr₹131 Cr₹39 Cr₹31 Cr₹22 Cr₹17 Cr₹65 Cr
₹415 Cr₹342 Cr₹288 Cr₹256 Cr₹222 Cr₹117 Cr₹109 Cr₹100 Cr₹95 Cr₹88 Cr
₹8 Cr₹6 Cr₹5 Cr₹4 Cr₹5 Cr₹7 Cr₹6 Cr₹5 Cr₹7 Cr₹6 Cr
₹2 Cr₹1 Cr₹2 Cr₹2 Cr₹1 Cr₹58 L₹42 L₹17 L₹12 L₹2 Cr
₹5 Cr₹4 Cr₹3 Cr₹3 Cr₹2 Cr₹0₹0₹0₹0₹0
₹15 Cr₹12 Cr₹10 Cr₹9 Cr₹8 Cr₹8 Cr₹6 Cr₹6 Cr₹7 Cr₹8 Cr
——————————
₹74 Cr₹44 Cr₹24 Cr₹20 Cr₹14 Cr₹32 Cr₹47 Cr₹20 Cr₹29 Cr₹19 Cr
₹21 Cr₹6 Cr₹6 Cr₹7 Cr₹3 Cr₹6 Cr₹4 Cr₹2 Cr₹86 L₹2 Cr
₹1 Cr₹5 Cr₹72 Cr₹83 Cr₹58 Cr₹12 Cr₹6 Cr₹6 Cr₹3 Cr₹2 Cr
₹9 Cr₹6 Cr₹6 Cr₹3 Cr₹4 Cr₹8 Cr₹9 Cr₹9 Cr₹8 Cr₹5 Cr
₹106 Cr₹62 Cr₹109 Cr₹113 Cr₹78 Cr₹59 Cr₹66 Cr₹37 Cr₹42 Cr₹28 Cr
₹536 Cr₹416 Cr₹407 Cr₹378 Cr₹308 Cr₹184 Cr₹181 Cr₹143 Cr₹144 Cr₹124 Cr
₹78 L₹86 L₹55 L₹55 L₹55 L₹3 Cr₹83 L₹83 L₹82 L₹2 Cr
₹1 Cr₹5 Cr₹72 Cr₹83 Cr₹58 Cr₹12 Cr₹6 Cr₹6 Cr₹3 Cr₹2 Cr
——————————
₹157 Cr₹146 Cr₹136 Cr₹102 Cr₹101 Cr₹92 Cr₹82 Cr₹80 Cr₹77 Cr₹74 Cr
₹67 Cr₹68 Cr₹63 Cr₹59 Cr₹54 Cr₹37 Cr₹37 Cr₹35 Cr₹27 Cr₹24 Cr
₹90 Cr₹78 Cr₹72 Cr₹43 Cr₹47 Cr₹55 Cr₹46 Cr₹46 Cr₹50 Cr₹50 Cr
₹0₹0₹0₹26 Cr₹6 Cr₹25 L₹5 Cr₹0₹0₹0
₹3 Cr₹4 Cr₹2 Cr₹2 Cr₹2 Cr₹36 Cr₹23 Cr₹6 Cr₹9 Cr₹7 Cr
₹3 Cr₹4 Cr₹2 Cr₹2 Cr₹2 Cr₹36 Cr₹23 Cr₹6 Cr₹9 Cr₹7 Cr
₹2 Cr₹1 Cr₹1 Cr₹2 Cr₹2 Cr₹6 Cr₹15 Cr₹7 Cr₹6 Cr₹5 Cr
₹16 Cr₹14 Cr₹7 Cr₹76 Cr₹64 Cr₹0₹0₹0₹0₹0
₹203 Cr₹143 Cr₹130 Cr₹196 Cr₹168 Cr₹97 Cr₹89 Cr₹59 Cr₹66 Cr₹62 Cr
——————————
₹107 Cr₹89 Cr₹64 Cr₹62 Cr₹41 Cr₹0₹0₹0₹0₹0
₹63 Cr₹41 Cr₹21 Cr₹21 Cr₹20 Cr₹10 Cr₹15 Cr₹11 Cr₹10 Cr₹6 Cr
₹111 Cr₹108 Cr₹103 Cr₹76 Cr₹68 Cr₹46 Cr₹46 Cr₹31 Cr₹29 Cr₹29 Cr
₹6 Cr₹71 L₹68 Cr₹9 Cr₹39 L₹7 Cr₹6 Cr₹7 Cr₹5 Cr₹4 Cr
₹7 Cr₹3 Cr₹1 Cr₹4 Cr₹3 Cr₹6 Cr₹6 Cr₹9 Cr₹6 Cr₹6 Cr
₹39 Cr₹30 Cr₹20 Cr₹10 Cr₹8 Cr₹18 Cr₹18 Cr₹25 Cr₹28 Cr₹17 Cr
₹333 Cr₹272 Cr₹277 Cr₹182 Cr₹140 Cr₹87 Cr₹92 Cr₹84 Cr₹78 Cr₹62 Cr
₹227 Cr₹211 Cr₹168 Cr₹69 Cr₹62 Cr₹28 Cr₹26 Cr₹47 Cr₹36 Cr₹33 Cr
₹536 Cr₹416 Cr₹407 Cr₹378 Cr₹308 Cr₹184 Cr₹181 Cr₹143 Cr₹144 Cr₹124 Cr
₹4₹4₹3₹3₹3₹2₹1₹1₹1₹39
₹4₹4₹3₹3₹3₹2₹1₹1₹1₹1

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013
₹101 Cr₹66 Cr₹34 Cr₹27 Cr₹26 Cr₹16 Cr₹16 Cr₹16 Cr₹14 Cr₹8 Cr
-₹30 Cr-₹11 Cr-₹3 Cr-₹6 Cr-₹7 Cr₹71 L₹1 Cr₹3 Cr₹2 Cr₹2 Cr
₹10 Cr-₹16 Cr-₹28 Cr-₹3 Cr₹4 Cr₹1 Cr₹12 Cr-₹12 Cr-₹6 Cr-₹3 Cr
₹81 Cr₹38 Cr₹2 Cr₹17 Cr₹23 Cr₹18 Cr₹30 Cr₹7 Cr₹11 Cr₹8 Cr
₹58 Cr₹23 Cr-₹6 Cr₹11 Cr₹16 Cr₹14 Cr₹24 Cr₹19 L₹7 Cr₹6 Cr
-₹51 Cr-₹18 Cr₹83 Cr-₹45 Cr-₹27 Cr-₹18 Cr-₹23 Cr₹63 L-₹4 Cr-₹32 L
-₹3 Cr-₹68 Cr-₹15 Cr₹35 Cr₹8 Cr₹5 Cr-₹2 Cr₹68 L-₹93 L-₹6 Cr
₹4 Cr-₹63 Cr₹63 Cr₹58 L-₹2 Cr₹83 L-₹1 Cr₹1 Cr₹2 Cr-₹92 L
₹71 L₹63 Cr₹88 L₹30 L₹3 Cr₹6 Cr₹7 Cr₹5 Cr₹4 Cr₹5 Cr
₹5 Cr₹71 L₹63 Cr₹88 L₹30 L₹7 Cr₹6 Cr₹7 Cr₹5 Cr₹4 Cr

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)22.45
Volume (₹)79.24 L
High (₹)22.45
Upper Circuit26.94
Low (₹)21.25
Lower Circuit17.96
Prev Close22.45
52W High (₹)27.49
Price21.56
52W Low (₹)10.21

Share Market Cap & Key Ratios Overview

M.Cap (₹)2112.18 Cr
Div. Yield (%)0.45
PE Ratio24.70
Debt to Equity0.00
Price to Book2.33
Book Value4.41
EPS (TTM)0.91
Face Value1.00
ROE (%)20.19

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
LAURUSLABSNSE
CIPLANSE
DRREDDYNSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
SYNCOMFNSE
LTP
1W Low
1W High
Market cap (₹)
1764+4 (0.23%)
1725.50
1778
4,19,620Cr
9030-310 (-3.32%)
8937.50
9431.50
2,39,714Cr
4584.1-72.8 (-1.56%)
4551.80
4682
1,74,741Cr
1140.2+22.7 (2.03%)
1107.30
1150.90
1,12,119Cr
2018.5-18.1 (-0.89%)
2007.80
2069.20
1,10,008Cr
1328+27 (2.08%)
1300.20
1336.40
1,06,061Cr
1218.8+21.8 (1.82%)
1196.90
1250.70
1,01,339Cr
2347.6-20.9 (-0.88%)
2317.50
2426.80
96,244Cr
1677.9-15.1 (-0.89%)
1647.10
1715
95,590Cr
1980.9+24.4 (1.25%)
1925.70
1990.90
89,391Cr
21.56-1.72 (-7.39%)
21.25
23.95
2,112Cr

Syncom Formulations (India) Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹34.04Cr; with other income of ₹7.83Cr, profit before interest and tax came to ₹32.5Cr. Interest expense was ₹24.5Lakh; PBT before exceptional items stood at ₹32.25Cr. Cost mix (full year): raw materials ₹278.13Cr; employee cost ₹50.56Cr; depreciation ₹1.54Cr; other expenses ₹99.32Cr. Basis: consolidated annual results.

Syncom Formulations (India) Ltd Quaterly Results Key Takeaways

Syncom Formulations (India) Ltd reported ₹125.53Cr total income from operations in Jun 2026, softer than ₹135.41Cr in Mar 2026 but higher than ₹116.9Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹34.04Cr; with other income of ₹7.83Cr, profit before interest and tax came to ₹32.5Cr. Interest expense was ₹24.5Lakh, taking profit before tax to ₹32.25Cr. After tax of ₹7.41Cr, profit after tax stood at ₹24.85Cr (vs ₹25.18Cr in Mar 2026 and ₹15.75Cr in Jun 2025).